Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Dainippon Sumitomo Pharma America |
---|---|
Information provided by: | Dainippon Sumitomo Pharma America |
ClinicalTrials.gov Identifier: | NCT00790192 |
Lurasidone HCl is a compound being developed for the treatment of schizophrenia. This clinical study is designed to test the hypothesis that lurasidone is effective, tolerable, and safe as compared with quetiapine XR short term among acutely psychotic patients with chronic schizophrenia.
Condition | Intervention | Phase |
---|---|---|
Schizophrenia |
Drug: Lurasidone HCl Drug: quetiapine XR Drug: Placebo |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Investigator), Parallel Assignment |
Official Title: | A Phase 3 Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Clinical Trial to Study the Efficacy and Safety of Two Doses of Lurasidone in Acutely Psychotic Subjects With Schizophrenia (PEARL 3) |
Estimated Enrollment: | 480 |
Study Start Date: | October 2008 |
Estimated Primary Completion Date: | December 2009 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Experimental |
Drug: Lurasidone HCl
Lurasidone HCl
|
2: Experimental |
Drug: Lurasidone HCl
Lurasidone HCl
|
3: Active Comparator |
Drug: quetiapine XR
Active Comparator
|
4: Placebo Comparator |
Drug: Placebo
Placebo
|
Ages Eligible for Study: | 18 Years to 75 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Kaushik Sarma, M.D. | 201-228-8040 | ksarma@dsp-a.com |
Responsible Party: | Dainippon Sumitomo Pharma America, Inc. ( Josephine Cucchiaro, Ph.D. / Senior Director, Clinical Development ) |
Study ID Numbers: | D1050233 |
Study First Received: | November 10, 2008 |
Last Updated: | November 12, 2008 |
ClinicalTrials.gov Identifier: | NCT00790192 |
Health Authority: | United States: Food and Drug Administration |
Acute Schizophrenia |
Schizophrenia Quetiapine Mental Disorders Psychotic Disorders Schizophrenia and Disorders with Psychotic Features |